BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 37342440)

  • 21. Role of hypertension in ischemic heart disease and cerebral vascular disease in the cynomolgus monkey with coarctation of the aorta.
    Hollander W; Prusty S; Kirkpatrick B; Paddock J; Nagraj S
    Circ Res; 1977 May; 40(5 Suppl 1):I70-83. PubMed ID: 140028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contribution of echocardiography to the diagnosis of patients with chronic heart failure].
    Pinamonti B
    Ital Heart J Suppl; 2000 Oct; 1(10):1311-6. PubMed ID: 11068713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salt sensitivity and left ventricular hypertrophy.
    Coca A; De la Sierra A
    Adv Exp Med Biol; 1997; 432():91-101. PubMed ID: 9433515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the Art lecture. Risk mechanisms in hypertensive heart disease.
    Frohlich ED
    Hypertension; 1999 Oct; 34(4 Pt 2):782-9. PubMed ID: 10523361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertensive heart disease. How does blood pressure affect left ventricular mass?
    Prisant LM; Houghton JL; Bottini PB; Carr AA
    Postgrad Med; 1994 May; 95(6):59-62, 66-76. PubMed ID: 8170874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent parameters of left atrium function in hypertensive heart disease.
    Salas Pacheco JL; Sánchez OL
    Echocardiography; 2019 Dec; 36(12):2195-2201. PubMed ID: 31755581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease.
    Strauer BE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S45-54. PubMed ID: 2468873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint study.
    Bang CN; Okin PM; Køber L; Wachtell K; Gottlieb AB; Devereux RB
    J Hypertens; 2014 Mar; 32(3):667-72. PubMed ID: 24379001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertensive Heart Disease-The Imaging Perspective.
    Ismail TF; Frey S; Kaufmann BA; Winkel DJ; Boll DT; Zellweger MJ; Haaf P
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine.
    Strauer BE; Atef Mahmoud M; Bayer F; Bohn I; Motz U
    Eur Heart J; 1984 Dec; 5 Suppl F():53-60. PubMed ID: 6241903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy.
    Strauer BE
    Am J Med; 1988 Mar; 84(3A):45-54. PubMed ID: 2975465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension and Heart Failure.
    Slivnick J; Lampert BC
    Heart Fail Clin; 2019 Oct; 15(4):531-541. PubMed ID: 31472888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM; Hille DA; Wachtell K; Kjeldsen SE; Boman K; Dahlöf B; Devereux RB
    J Hypertens; 2015 Jul; 33(7):1480-6. PubMed ID: 25799208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure.
    Pluteanu F; Nikonova Y; Holzapfel A; Herzog B; Scherer A; Preisenberger J; Plačkić J; Scheer K; Ivanova T; Bukowska A; Goette A; Kockskämper J
    J Mol Cell Cardiol; 2018 Jan; 114():253-263. PubMed ID: 29191788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigation.
    Reiffel JA
    Am J Hypertens; 2004 Mar; 17(3):213-6. PubMed ID: 15001193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of heart rate on coronary circulation and external mechanical efficiency in elderly hypertensive patients with left ventricular hypertrophy.
    Ishibashi Y; Shimada T; Nosaka S; Sano K; Oyake N; Kobayashi S; Umeno T; Yoshitomi H; Morioka S
    Clin Cardiol; 1996 Aug; 19(8):620-30. PubMed ID: 8864335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.